Congressional Hearing: FDA’s Review Process for Products to Treat Rare Diseases and Neglected Tropical Diseases

  Tweet

The Agriculture Appropriations subcommittee presents a hearing on 
FDA's review process for products to treat rare diseases and neglected tropical diseases 

Wednesday, June 23, 2010 
2:00pm--4:00pm 

in 
Dirksen Senate Office Building, Room 192
Washington, DC 

Watch the Hearing

Witnesses will include: 
Dr. Chris Austin, NIH, National Human Genome Research Institute and the Therapeutics for Rare and Neglected Diseases program 
Thomas Bollyky, Visiting Fellow, Center for Global Development 
Dr. Jesse Goodman, FDA Chief Scientist and Deputy Commissioner for Science and Public Health 
Gloria Steele, USAID Senior Deputy Assistant Administrator for Global Health

Read Bollyky's testimony

  Tweet

Event Type

• Other

Location

• Dirksen Senate Office Building, Room 192
• View on map

Time

• 2:00 PM - 4:00 PM

Research Topics

• Global Health Policy

CGD Experts

Thomas Bollyky
Former Research Fellow

Publications

• Bridging the Gap: Better, Faster, and Cheaper Clinical Trials for Health Products for Neglected Diseases - Working Paper 217
• FDA’s Role in Improving the Development Pathway for Neglected Disease Therapies - Congressional Testimony